Company intelligence / Profile preview

Vektor Medical

San Diego, California, United Statesvektormedical.com ↗

Ownership: Private
Employees: ~49
Development stage: Commercial

Overview

vMap has demonstrated significant clinical adoption with strong evidence supporting its ability to localize and map multiple types of cardiac arrhythmias non-invasively using standard ECG data. Clinical studies have shown improved ablation outcomes and workflow efficiency. The company continues to expand post-market studies and pivotal trials.

Therapeutic areas: Cardiovascular
Modalities: Device (AI-powered software)Non-pharmacological therapy (diagnostic/analysis tool)Artificial intelligence-based analysis
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

vMap

Commercial

Indications: Cardiac arrhythmia, Atrial fibrillation, Ventricular tachycardia, Atrial tachycardia, Ventricular fibrillation

Beyond the preview

Go deeper on Vektor Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vektor Medical.

Explore the full profile